nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—ADRB2—polycystic ovary syndrome	0.799	1	CbGaD
Esmolol—Angina unstable—Metformin—polycystic ovary syndrome	0.00964	0.168	CcSEcCtD
Esmolol—Rigors—Metformin—polycystic ovary syndrome	0.00298	0.052	CcSEcCtD
Esmolol—Neuropathy—Metformin—polycystic ovary syndrome	0.00229	0.0399	CcSEcCtD
Esmolol—Lightheadedness—Metformin—polycystic ovary syndrome	0.00218	0.038	CcSEcCtD
Esmolol—Nasal congestion—Metformin—polycystic ovary syndrome	0.00194	0.0339	CcSEcCtD
Esmolol—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00158	0.0276	CcSEcCtD
Esmolol—Angina pectoris—Metformin—polycystic ovary syndrome	0.00149	0.026	CcSEcCtD
Esmolol—Sweating increased—Metformin—polycystic ovary syndrome	0.00149	0.026	CcSEcCtD
Esmolol—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00146	0.0256	CcSEcCtD
Esmolol—Drowsiness—Metformin—polycystic ovary syndrome	0.00136	0.0238	CcSEcCtD
Esmolol—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00133	0.0233	CcSEcCtD
Esmolol—Bradycardia—Metformin—polycystic ovary syndrome	0.00124	0.0217	CcSEcCtD
Esmolol—Rhinitis—Metformin—polycystic ovary syndrome	0.00123	0.0214	CcSEcCtD
Esmolol—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00113	0.0198	CcSEcCtD
Esmolol—Flushing—Metformin—polycystic ovary syndrome	0.00113	0.0198	CcSEcCtD
Esmolol—Angiopathy—Metformin—polycystic ovary syndrome	0.00111	0.0194	CcSEcCtD
Esmolol—Chills—Metformin—polycystic ovary syndrome	0.0011	0.0191	CcSEcCtD
Esmolol—Erythema—Metformin—polycystic ovary syndrome	0.00106	0.0186	CcSEcCtD
Esmolol—Dysgeusia—Metformin—polycystic ovary syndrome	0.00104	0.0182	CcSEcCtD
Esmolol—Alprenolol—ADRB3—polycystic ovary syndrome	0.000966	0.0945	CrCbGaD
Esmolol—Syncope—Metformin—polycystic ovary syndrome	0.000954	0.0167	CcSEcCtD
Esmolol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000935	0.0163	CcSEcCtD
Esmolol—Chest pain—Metformin—polycystic ovary syndrome	0.000906	0.0158	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0009	0.0157	CcSEcCtD
Esmolol—Oedema—Metformin—polycystic ovary syndrome	0.000868	0.0152	CcSEcCtD
Esmolol—Shock—Metformin—polycystic ovary syndrome	0.000854	0.0149	CcSEcCtD
Esmolol—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000852	0.0149	CcSEcCtD
Esmolol—Skin disorder—Metformin—polycystic ovary syndrome	0.000844	0.0147	CcSEcCtD
Esmolol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00084	0.0147	CcSEcCtD
Esmolol—Bevantolol—ADRA1A—polycystic ovary syndrome	0.000834	0.0816	CrCbGaD
Esmolol—Pindolol—ADRB3—polycystic ovary syndrome	0.000831	0.0813	CrCbGaD
Esmolol—Anorexia—Metformin—polycystic ovary syndrome	0.000828	0.0144	CcSEcCtD
Esmolol—Hypotension—Metformin—polycystic ovary syndrome	0.000812	0.0142	CcSEcCtD
Esmolol—Ibuprofen—PLAT—polycystic ovary syndrome	0.00078	0.0764	CrCbGaD
Esmolol—Paraesthesia—Metformin—polycystic ovary syndrome	0.00078	0.0136	CcSEcCtD
Esmolol—Dyspnoea—Metformin—polycystic ovary syndrome	0.000774	0.0135	CcSEcCtD
Esmolol—Somnolence—Metformin—polycystic ovary syndrome	0.000772	0.0135	CcSEcCtD
Esmolol—Dyspepsia—Metformin—polycystic ovary syndrome	0.000764	0.0133	CcSEcCtD
Esmolol—Decreased appetite—Metformin—polycystic ovary syndrome	0.000755	0.0132	CcSEcCtD
Esmolol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00075	0.0131	CcSEcCtD
Esmolol—Fatigue—Metformin—polycystic ovary syndrome	0.000749	0.0131	CcSEcCtD
Esmolol—Constipation—Metformin—polycystic ovary syndrome	0.000743	0.013	CcSEcCtD
Esmolol—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000716	0.0125	CcSEcCtD
Esmolol—Urticaria—Metformin—polycystic ovary syndrome	0.00069	0.012	CcSEcCtD
Esmolol—Metipranolol—ADRB2—polycystic ovary syndrome	0.000632	0.0619	CrCbGaD
Esmolol—Asthenia—Metformin—polycystic ovary syndrome	0.000623	0.0109	CcSEcCtD
Esmolol—Pruritus—Metformin—polycystic ovary syndrome	0.000614	0.0107	CcSEcCtD
Esmolol—Dizziness—Metformin—polycystic ovary syndrome	0.000574	0.01	CcSEcCtD
Esmolol—Sotalol—ADRB2—polycystic ovary syndrome	0.000563	0.0551	CrCbGaD
Esmolol—Vomiting—Metformin—polycystic ovary syndrome	0.000552	0.00964	CcSEcCtD
Esmolol—Headache—Metformin—polycystic ovary syndrome	0.000544	0.0095	CcSEcCtD
Esmolol—Nausea—Metformin—polycystic ovary syndrome	0.000516	0.009	CcSEcCtD
Esmolol—Chlorphenesin—CYP19A1—polycystic ovary syndrome	0.000511	0.05	CrCbGaD
Esmolol—Bevantolol—ADRB2—polycystic ovary syndrome	0.000496	0.0485	CrCbGaD
Esmolol—Propranolol—ADRB3—polycystic ovary syndrome	0.000453	0.0444	CrCbGaD
Esmolol—Ibuprofen—BCL2—polycystic ovary syndrome	0.000448	0.0439	CrCbGaD
Esmolol—Betaxolol—ADRB2—polycystic ovary syndrome	0.000442	0.0433	CrCbGaD
Esmolol—Atenolol—ADRB2—polycystic ovary syndrome	0.000438	0.0429	CrCbGaD
Esmolol—Bisoprolol—ADRB2—polycystic ovary syndrome	0.000427	0.0418	CrCbGaD
Esmolol—Acebutolol—ADRB2—polycystic ovary syndrome	0.000404	0.0396	CrCbGaD
Esmolol—Oxprenolol—ADRB2—polycystic ovary syndrome	0.000401	0.0393	CrCbGaD
Esmolol—Alprenolol—ADRB2—polycystic ovary syndrome	0.000367	0.0359	CrCbGaD
Esmolol—ADRB2—GPCR ligand binding—NPB—polycystic ovary syndrome	0.000353	0.00263	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.000351	0.00262	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.000349	0.00261	CbGpPWpGaD
Esmolol—Metoprolol—ADRB2—polycystic ovary syndrome	0.000341	0.0334	CrCbGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.000341	0.00255	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.000337	0.00252	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000332	0.00248	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00033	0.00247	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000325	0.00243	CbGpPWpGaD
Esmolol—Pindolol—ADRB2—polycystic ovary syndrome	0.000316	0.0309	CrCbGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.000309	0.00231	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.000302	0.00226	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000301	0.00225	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000301	0.00225	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000297	0.00222	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000294	0.0022	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000294	0.0022	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000291	0.00217	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000289	0.00216	CbGpPWpGaD
Esmolol—ADRB1—G alpha (s) signalling events—ADRB2—polycystic ovary syndrome	0.000288	0.00215	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000283	0.00211	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000281	0.0021	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000275	0.00206	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000273	0.00204	CbGpPWpGaD
Esmolol—ADRB1—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.000267	0.002	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000267	0.002	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000266	0.00199	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.000264	0.00198	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000262	0.00196	CbGpPWpGaD
Esmolol—ADRB2—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.000261	0.00195	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00026	0.00194	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.000259	0.00193	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000257	0.00192	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000255	0.0019	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000251	0.00188	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000249	0.00186	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.000249	0.00186	CbGpPWpGaD
Esmolol—Ibuprofen—PPARG—polycystic ovary syndrome	0.000248	0.0243	CrCbGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000246	0.00184	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000246	0.00184	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00024	0.0018	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000231	0.00172	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000226	0.00169	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000225	0.00168	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00022	0.00165	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00022	0.00164	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000215	0.00161	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000204	0.00152	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000201	0.0015	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000199	0.00149	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000197	0.00147	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000194	0.00145	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000192	0.00143	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00019	0.00142	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000187	0.0014	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000187	0.0014	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000185	0.00138	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000184	0.00138	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000183	0.00137	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000181	0.00135	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00018	0.00135	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00018	0.00135	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00018	0.00135	CbGpPWpGaD
Esmolol—ADRB1—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.00018	0.00135	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000179	0.00134	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000176	0.00132	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000176	0.00132	CbGpPWpGaD
Esmolol—ADRB2—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000176	0.00132	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000176	0.00131	CbGpPWpGaD
Esmolol—Propranolol—ADRB2—polycystic ovary syndrome	0.000172	0.0169	CrCbGaD
Esmolol—ADRB1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000171	0.00128	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00017	0.00127	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00017	0.00127	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000167	0.00125	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000167	0.00125	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000166	0.00124	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000166	0.00124	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000166	0.00124	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000164	0.00122	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000162	0.00121	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00016	0.0012	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000159	0.00119	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000156	0.00116	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000154	0.00115	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000154	0.00115	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000154	0.00115	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000151	0.00113	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000151	0.00113	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000151	0.00113	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00015	0.00112	CbGpPWpGaD
Esmolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.000148	0.0145	CrCbGaD
Esmolol—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000147	0.0011	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000144	0.00108	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000141	0.00106	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00014	0.00105	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000137	0.00103	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000137	0.00102	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000137	0.00102	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000136	0.00102	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000134	0.000999	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000133	0.000997	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000126	0.000945	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000125	0.000934	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000124	0.00093	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000124	0.000927	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000124	0.000924	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000122	0.000914	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000122	0.000909	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000121	0.000907	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000114	0.00085	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000113	0.000844	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000111	0.000832	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000111	0.000826	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00011	0.000819	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000109	0.000816	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000108	0.000809	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000107	0.000801	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000107	0.000799	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000106	0.000791	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000106	0.000791	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000105	0.000782	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000103	0.000773	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000103	0.000772	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000101	0.000758	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000101	0.000755	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	9.95e-05	0.000743	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	9.92e-05	0.000741	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	9.88e-05	0.000738	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	9.83e-05	0.000735	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	9.73e-05	0.000727	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	9.7e-05	0.000725	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	9.67e-05	0.000723	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	9.66e-05	0.000722	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	9.61e-05	0.000719	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	9.61e-05	0.000718	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	9.49e-05	0.000709	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	9.46e-05	0.000707	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	9.4e-05	0.000702	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	9.21e-05	0.000688	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	9.12e-05	0.000681	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	9.12e-05	0.000681	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	9.01e-05	0.000673	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.92e-05	0.000667	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.92e-05	0.000667	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	8.79e-05	0.000657	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	8.59e-05	0.000642	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	8.58e-05	0.000641	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	8.53e-05	0.000637	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	8.39e-05	0.000627	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	8.34e-05	0.000623	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	8.28e-05	0.000619	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	8.1e-05	0.000605	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	8.05e-05	0.000602	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.88e-05	0.000589	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	7.85e-05	0.000587	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	7.68e-05	0.000574	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	7.33e-05	0.000548	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	7.17e-05	0.000536	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	7.15e-05	0.000534	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.99e-05	0.000522	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	6.67e-05	0.000499	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	6.53e-05	0.000488	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	6.53e-05	0.000488	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.49e-05	0.000485	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	6.39e-05	0.000478	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.35e-05	0.000474	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	6.27e-05	0.000469	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	6.14e-05	0.000459	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	6.1e-05	0.000456	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.97e-05	0.000446	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	5.95e-05	0.000445	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	5.91e-05	0.000442	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.88e-05	0.000439	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	5.82e-05	0.000435	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	5.81e-05	0.000434	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.75e-05	0.00043	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	5.68e-05	0.000424	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.67e-05	0.000424	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.55e-05	0.000415	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.5e-05	0.000411	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.48e-05	0.00041	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	5.44e-05	0.000407	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.38e-05	0.000402	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	5.37e-05	0.000401	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.36e-05	0.000401	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	5.32e-05	0.000398	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	5.19e-05	0.000388	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	5.1e-05	0.000381	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	5.08e-05	0.000379	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	5.06e-05	0.000378	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.99e-05	0.000373	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.98e-05	0.000372	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.95e-05	0.00037	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.87e-05	0.000364	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	4.72e-05	0.000353	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	4.66e-05	0.000348	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	4.62e-05	0.000345	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	4.56e-05	0.00034	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	4.45e-05	0.000333	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	4.36e-05	0.000326	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.23e-05	0.000316	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.16e-05	0.000311	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.14e-05	0.000309	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	4.12e-05	0.000308	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.07e-05	0.000304	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	4.03e-05	0.000301	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.83e-05	0.000286	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.83e-05	0.000286	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.75e-05	0.00028	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.75e-05	0.00028	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.69e-05	0.000276	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.66e-05	0.000273	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.61e-05	0.00027	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.58e-05	0.000267	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.57e-05	0.000267	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.55e-05	0.000265	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.49e-05	0.000261	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.47e-05	0.000259	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	3.37e-05	0.000252	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	3.35e-05	0.000251	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	3.34e-05	0.00025	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	3.3e-05	0.000247	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	3.28e-05	0.000245	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	3.27e-05	0.000245	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.22e-05	0.000241	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.17e-05	0.000237	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.15e-05	0.000236	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.94e-05	0.00022	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.88e-05	0.000215	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.8e-05	0.000209	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.75e-05	0.000206	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.74e-05	0.000205	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.69e-05	0.000201	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.36e-05	0.000176	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	2.31e-05	0.000172	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.3e-05	0.000172	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	2.26e-05	0.000169	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.06e-05	0.000154	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.01e-05	0.00015	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.98e-05	0.000148	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.97e-05	0.000147	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.94e-05	0.000145	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.93e-05	0.000144	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.91e-05	0.000142	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.9e-05	0.000142	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.86e-05	0.000139	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.86e-05	0.000139	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.81e-05	0.000135	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.77e-05	0.000132	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.46e-05	0.000109	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.43e-05	0.000107	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.24e-05	9.3e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.22e-05	9.1e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	8.61e-06	6.43e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	8.42e-06	6.29e-05	CbGpPWpGaD
